COMPANY
History
History of NeuroBiogen 2019 - Current
2025
  • Tisolagiline(KDS2010) Lisence Out Agreement to Scilex Bio Inc.
2024
  • Approval of Tisolagiline IND filing for the phase 2a clinical trial on obesity
  • Approval of Tisolagiline IND filing for the phase 2a clinical trial on Alzheimer’s disease
  • Tisolagiline phase 1 clinical trial CSR issue
2023
  • Material and Use Patents of Tisolagiline Registered in Brazil
  • Tisolagiline phase 1 clinical trial completed
  • Won the public R&D project support agreement by Korea Health Industry Development Institute (KHIDI) and Korea Dementia Research Center (KDRC), under the Ministry of Health & Welfare
2022
  • Material and Use Patents of Tisolagiline Registered in India
  • Approval of Tisolagiline IND filing for the phase 1 clinical trial
2021
  • Series A investment attraction complete
2020
  • Material and Use Patents of Tisolagiline Registered in US, Canada, China
2019
  • License in/Transfer of Tisolagiline from MegaBioWood
  • Establish of NeuroBiogen